Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Brawn Biotech LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:530207NSE Symbol: Not ListedP/E(TTM):0
ISIN Demat:INE899B01015Div & Yield %:0EPS(TTM):0
Book Value(Rs):14.101Market Cap ( Cr.):7.15Face Value(Rs):10
    Change Company 
Date Headline
14-Nov-24 Brawn Biotech reports standalone net loss of Rs0.34 crore in the September 2024 quarter
11-Nov-24 Brawn Biotech to conduct board meeting
05-Sep-24 Brawn Biotech to conduct AGM
27-Aug-24 Brawn Biotech Ltd - Board Meeting Outcome for OUTCOME OF BOARD MEETING FOR CHANGE IN MANAGEMENT W.R.T APPOINTMENT AND RE..
27-Aug-24 Brawn Biotech Ltd - Announcement under Regulation 30 (LODR)-Change in Management
27-Aug-24 Brawn Biotech Ltd - Announcement under Regulation 30 (LODR)-Resignation of Director
14-Aug-24 Brawn Biotech Ltd - Board Meeting Outcome for Outcome Of Board Meeting
14-Aug-24 Brawn Biotech Ltd - Result For The Quarter Ended 30/06/2024
12-Aug-24 Brawn Biotech to discuss results
14-Jun-24 Brawn Biotech Ltd - Declaration Under Regulation 33(3)(D) Of SEBI (Listing Obligations And Disclosures Requirements) Reg..
<< < 1 2 > >>